BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25779943)

  • 21. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.
    Johansson P; Klein-Hitpass L; Grabellus F; Arnold G; Klapper W; Pförtner R; Dührsen U; Eckstein A; Dürig J; Küppers R
    Oncotarget; 2016 Sep; 7(38):62627-62639. PubMed ID: 27566587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
    Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
    Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
    Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
    Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
    Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
    Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and phenotypic attributes of splenic marginal zone lymphoma.
    Bonfiglio F; Bruscaggin A; Guidetti F; Terzi di Bergamo L; Faderl M; Spina V; Condoluci A; Bonomini L; Forestieri G; Koch R; Piffaretti D; Pini K; Pirosa MC; Cittone MG; Arribas A; Lucioni M; Ghilardi G; Wu W; Arcaini L; Baptista MJ; Bastidas G; Bea S; Boldorini R; Broccoli A; Buehler MM; Canzonieri V; Cascione L; Ceriani L; Cogliatti S; Corradini P; Derenzini E; Devizzi L; Dietrich S; Elia AR; Facchetti F; Gaidano G; Garcia JF; Gerber B; Ghia P; Gomes da Silva M; Gritti G; Guidetti A; Hitz F; Inghirami G; Ladetto M; Lopez-Guillermo A; Lucchini E; Maiorana A; Marasca R; Matutes E; Meignin V; Merli M; Moccia A; Mollejo M; Montalban C; Novak U; Oscier DG; Passamonti F; Piazza F; Pizzolitto S; Rambaldi A; Sabattini E; Salles G; Santambrogio E; Scarfò L; Stathis A; Stüssi G; Geyer JT; Tapia G; Tarella C; Thieblemont C; Tousseyn T; Tucci A; Vanini G; Visco C; Vitolo U; Walewska R; Zaja F; Zenz T; Zinzani PL; Khiabanian H; Calcinotto A; Bertoni F; Bhagat G; Campo E; De Leval L; Dirnhofer S; Pileri SA; Piris MA; Traverse-Glehen A; Tzankov A; Paulli M; Ponzoni M; Mazzucchelli L; Cavalli F; Zucca E; Rossi D
    Blood; 2022 Feb; 139(5):732-747. PubMed ID: 34653238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [IGHV mutational statue in patients with splenic marginal zone lymphoma].
    Yang WJ; Yu Z; Lyu R; Li ZJ; Li H; Xiong WJ; Yi SH; Liu W; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):774-778. PubMed ID: 27719720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.
    Jaramillo Oquendo C; Parker H; Oscier D; Ennis S; Gibson J; Strefford JC
    Sci Rep; 2019 Jul; 9(1):10444. PubMed ID: 31320741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
    Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F
    Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
    Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
    J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
    Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
    Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
    Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
    Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.
    Nocturne G; Boudaoud S; Miceli-Richard C; Viengchareun S; Lazure T; Nititham J; Taylor KE; Ma A; Busato F; Melki J; Lessard CJ; Sivils KL; Dubost JJ; Hachulla E; Gottenberg JE; Lombès M; Tost J; Criswell LA; Mariette X
    Blood; 2013 Dec; 122(25):4068-76. PubMed ID: 24159176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
    Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
    Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
    Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
    Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
    Zhu D; Ikpatt OF; Dubovy SR; Lossos C; Natkunam Y; Chapman-Fredricks JR; Fan YS; Lossos IS
    Am J Hematol; 2013 Sep; 88(9):730-5. PubMed ID: 23720088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
    Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
    Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.
    Piva R; Deaglio S; Famà R; Buonincontri R; Scarfò I; Bruscaggin A; Mereu E; Serra S; Spina V; Brusa D; Garaffo G; Monti S; Dal Bo M; Marasca R; Arcaini L; Neri A; Gattei V; Paulli M; Tiacci E; Bertoni F; Pileri SA; Foà R; Inghirami G; Gaidano G; Rossi D
    Leukemia; 2015 Feb; 29(2):503-7. PubMed ID: 25283840
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
    Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
    Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.